NEWS

News Articles

Atlanta’s next big thing: world hub for health innovation, preparedness

February 21, 2020

Backers of a two-year effort to capitalize on Atlanta’s maturing health and medical sector are close to revealing details of a new health care innovation district that could galvanize the city’s next big technology boom, The Atlanta Journal-Constitution has learned. The proposed innovation hub has the potential to lure thousands of high-paying jobs to the…

Read More

Cambium Enrolls Final Patient in Phase I/II Dry Eye Study

February 20, 2020

ATLANTA, GA – February 20, 2020 – Cambium Medical Technologies (“Cambium”), a clinical stage company developing novel processed platelets for various therapeutic applications, announced the final patient was enrolled in Dec. 2019 for its Elate Ocular® topical fibrinogen-depleted human platelet lysate biologic in a randomized, multicenter, double-masked placebo-controlled parallel Phase I/II study.  The study is…

Read More

Inside a lab where scientists are working urgently to fight the coronavirus outbreak

February 14, 2020

BALTIMORE — The novel coronavirus at the center of a widening global public health emergency arrived here last Friday in two thumb-size vials, nested in dry ice and multiple layers of protective packaging. The samples, from the Centers for Disease Control and Prevention in Atlanta, remained in deep freeze until Monday afternoon, when virologist Matthew Frieman at…

Read More

Georgia Bio Names 2020 Golden Helix Award Winners

January 30, 2020

UCB’s Patty Fritz and Quick Start’s Philip Gibson Honored ATLANTA–(BUSINESS WIRE)–Georgia Bio, the state’s life science trade association, will celebrate its Golden Helix Awards & Annual Gala on Friday, March 13th at Factory Atlanta in Chamblee. Georgia Bio is pleased to announce the winners of the 2020 Golden Helix Awards. Patty Fritz, Georgia Bio Chair and…

Read More

Charles River pens Takeda early-stage drugs deal

January 13, 2020

At the annual J.P. Morgan Healthcare Conference, major CRO Charles River Laboratories and Japanese Big Pharma Takeda announced a new preclinical tie-up. The pair will “launch multiple integrated programs across Takeda’s four core therapeutic areas,” they said in a statement, namely: oncology, gastroenterology, neuroscience and rare disease, with Charles River being tasked with moving its preclinical…

Read More

Augusta University Health announces first-ever chief innovation officer

January 6, 2020

Mallary Myers, a national leader in clinical innovation, has been named vice president/chief innovation officer for Augusta University Health, effective Jan. 3. In this role, Myers will be responsible for promoting a culture of innovation across the health system, including working closely with hospital leadership and AU Health Information Technology to nurture concepts to streamline overall health…

Read More